Varenicline induced auditory hallucinations in a young female with bipolar disorder: a case report.
Vivian W L TsangSaundarai BhanotLingsa JiaPublished in: BMC psychiatry (2023)
The occurrence of side effects as a result of varenicline use in patients with diagnosed mental health conditions is rare and underlying psychiatric illness is not labeled as an absolute contraindication in the prescription of varenicline. However, it is important to advocate for increased guidance and research on the treatment of substance use disorders in patients with bipolar I disorder. Patients may also benefit from increased collaboration between psychiatric and addiction services as that may allow for earlier recognition and intervention of symptoms to minimize distress.
Keyphrases
- mental health
- bipolar disorder
- smoking cessation
- replacement therapy
- end stage renal disease
- newly diagnosed
- randomized controlled trial
- ejection fraction
- major depressive disorder
- primary care
- chronic kidney disease
- healthcare
- risk assessment
- peritoneal dialysis
- mental illness
- prognostic factors
- high glucose
- diabetic rats
- combination therapy
- patient reported outcomes
- physical activity
- sleep quality
- endothelial cells
- middle aged
- hearing loss
- positron emission tomography
- pet ct